FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to surgery. Method is carried out by means of isolating from the focus of purulent inflammation of patients with diabetic foot syndrome of 10 pure cultures of microorganisms of the same species, their sensitivity to antimicrobial drugs is determined by means of the disc diffusion test, while the antibiotic or the combination of antibiotics is selected, to which all cultures (clonal lines) of microorganisms are sensitive.
EFFECT: invention can be used in order to select the antimicrobial drug (antibiotic) or the combination of antibiotics that are most effective in treating purulent complications of the diabetic foot syndrome of microbial etiology.
1 cl, 6 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF LOW-DIMENSIONAL BIDIMENTIONAL (2D) FOLDED STRUCTURES OF ALUMINUM OXYHYDROXIDE (ALOOH) TO OVERCOME RESISTANCE OF BACTERIA TO ANTIBIOTICS | 2018 |
|
RU2705989C1 |
| METHOD OF BONE CAVITIES REPLACEMENT IN TREATMENT OF PATIENTS WITH CHRONIC OSTEOMYELITIS | 2019 |
|
RU2710252C1 |
| METHOD FOR MANUFACTURING A CEMENT SPACER FOR ETIOTROPIC LOCAL ANTIBACTERIAL THERAPY FOR INFECTIOUS AFFECTIONS OF BONES AND JOINTS | 2020 |
|
RU2754075C1 |
| METHOD FOR TREATING SKIN AND SOFT TISSUE WOUNDS USING A WOUND DRESSING BASED ON BACTERIAL CELLULOSE | 2022 |
|
RU2793743C1 |
| METHOD OF TREATING INFECTED WOUNDS IN EXPERIMENT | 2011 |
|
RU2466720C2 |
| ANTIMICROBIAL COMPOSITION FOR FORMING A SPACER | 2019 |
|
RU2707734C1 |
| NIOSOMAL ANTIMICROBIAL GEL FOR TREATING DIABETIC ULCERS, WOUNDS, BURNS, INCLUDING THOSE INFECTED WITH ANTIBIOTIC-RESISTANT MICROORGANISMS | 2021 |
|
RU2781402C2 |
| MEDICINAL PRODUCT FOR THE TREATMENT OF ULCER DEFECTS IN "DIABETIC FOOT" SYNDROME | 2023 |
|
RU2804781C1 |
| METHOD FOR KILLING MICROORGANISMS IN BIOFILMS | 2022 |
|
RU2802523C1 |
| HEMOSTATIC ANTIBACTERIAL AGENT, METHOD FOR ITS PREPARATION, MEDICAL PRODUCT BASED ON HEMOSTATIC ANTIBACTERIAL AGENT | 2016 |
|
RU2665950C2 |
